CARY, N.C.--(BUSINESS WIRE)--JMP® Clinical 3, just released by business analytics leader SAS, offers new ways to interactively explore safety data in clinical trials, streamlining the review process ...
Investing.com - Citizens JMP has reiterated its Market Outperform rating and $5.00 price target on Sana Biotechnology (NASDAQ:SANA) following updated clinical data from its diabetes treatment program.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback